Last updated: 15th September 2026
These Terms and Conditions (“Terms”) govern the use of the Cellbyte platform and services (“Cellbyte Services”) provided by Cellbyte GmbH (“Cellbyte”, “we”, “us”, or “our”) to its customers (“Customer” or “you”).
Subject to these Terms and payment of applicable fees, Cellbyte grants the Customer a non-exclusive, non-transferable, revocable license to access and use the Cellbyte Services solely for internal business purposes related to pharmaceutical pricing and market access.
Cellbyte Services are provided on a subscription basis. The Customer selects a subscription plan (e.g., monthly or annual) in the Order Form.
Cellbyte may adjust fees for subsequent subscription periods in the event of material cost changes, with prior written notice.
The Customer shall not:
Both parties agree to keep confidential all non-public information disclosed during the term of this Agreement.
Confidential information includes proprietary data, technical information, and business information.
Confidentiality obligations do not apply to information that is:
Confidentiality obligations remain in effect for five (5) years after termination.
Cellbyte commits to providing the Services with a minimum uptime of 99% during each Subscription Term.
Support is available:
Cellbyte warrants that the Services will substantially conform to the published documentation.
No warranty is made regarding uninterrupted or error-free operation.
Except as expressly stated, the Services are provided "as is", without implied warranties of merchantability or fitness for a particular purpose.
The Customer agrees to indemnify and hold harmless Cellbyte from claims arising from misuse of the Services or violation of these Terms.
Either party may terminate by providing 30 days' written notice prior to the end of the Subscription Term.
Either party may terminate immediately if the other party materially breaches this Agreement and fails to cure within 30 days of written notice.
These Terms are governed by the laws of Germany.
Any disputes will be subject to the exclusive jurisdiction of the courts of Munich, Germany.
Amendments to these Terms must be made in writing and signed by both parties.
Neither party may assign its rights under this Agreement without prior written consent, except in connection with a merger or sale of substantially all assets.
Neither party is liable for delays or failures caused by events outside reasonable control, including natural disasters, strikes, or other force majeure events.
These Terms, together with incorporated documents (such as the DPA), constitute the entire agreement between the parties and supersede all prior discussions or agreements.